[Skip to Content]

safety

Safety Alert – Zeiss Lucia 611P intraocular lens

The College has been made aware of two ophthalmic units with a run of a small number of cases of fibrin membrane deposition in association with the Zeiss Lucia 611P intraocular lens. In these cases, the patients presented from a few days up to 6 weeks postoperatively, with a painless white eye, very mild or

Ophthalmic Safety Alert- Do not use apraclonidine in infants below six months of age

The College has recently received a report from NHS Improvement of a severe adverse reaction in a six month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.  Two drops of apraclonidine 1% were administered to each eye, 30 minutes apart.  Ninety minutes later the child had an acute

Ozurdex recall alert

Allergan Pharmaceuticals Ireland is recalling numerous batches of Ozurdex due to the possibility that a single loose silicone particle of approximately 300 microns in diameter may become detached from the needle sleeve during administration of the implant and may be delivered into the eye along with the implant. The MHRA have issued the following alert

Ophthalmic Safety Alert – Diabetic control and safe cataract surgery

The College has received queries from members to clarify whether there is a specific cut off for glycaemic control, either measured via HbA1C or a blood glucose level on the day, beyond which it is unsafe to proceed with cataract surgery. There is anecdotal evidence of cataract surgery cases being cancelled for surgery if their

Ophthalmic Safety Alert – intracameral cefuroxime

There are a range of cefuroxime preparations currently in use for the prevention of endophthalmitis in intraocular surgery. There are two licensed versions, Aprokam (Thea Pharmaceuticals) and  Ximaract (from Bausch & Lomb), both available as a  50mg powder and diluent solution for injection.  Also used are unlicensed prefilled syringes, of which some are compliant with